Barbara E Murray Selected Research

Cefazolin (Ancef)

1/2021	A Test for the Rapid Detection of the Cefazolin Inoculum Effect in Methicillin-Susceptible Staphylococcus aureus.
12/2020	Cefazolin and Ertapenem Salvage Therapy Rapidly Clears Persistent Methicillin-Susceptible Staphylococcus aureus Bacteremia.
11/2018	Adjunctive Clavulanic Acid Abolishes the Cefazolin Inoculum Effect in an Experimental Rat Model of Methicillin-Sensitive Staphylococcus aureus Endocarditis.
1/2017	Efficacy of Ceftaroline against Methicillin-Susceptible Staphylococcus aureus Exhibiting the Cefazolin High-Inoculum Effect in a Rat Model of Endocarditis.
12/2013	Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitals.
9/2013	In Vivo Effects of Cefazolin, Daptomycin, and Nafcillin in Experimental Endocarditis with a Methicillin-Susceptible Staphylococcus aureus Strain Showing an Inoculum Effect against Cefazolin.
8/2009	Inoculum effect with cefazolin among clinical isolates of methicillin-susceptible Staphylococcus aureus: frequency and possible cause of cefazolin treatment failure.
11/2003	Relapse of type A beta-lactamase-producing Staphylococcus aureus native valve endocarditis during cefazolin therapy: revisiting the issue.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Barbara E Murray Research Topics

Disease

41	Endocarditis 12/2020 - 03/2002
37	Infections 01/2021 - 03/2003
9	Urinary Tract Infections (Urinary Tract Infection) 01/2021 - 11/2007
9	Peritonitis 01/2021 - 02/2003
8	Bacteremia 12/2020 - 12/2005
6	Body Weight (Weight, Body) 01/2018 - 02/2003
4	Sepsis (Septicemia) 01/2017 - 04/2014
3	Communicable Diseases (Infectious Diseases) 01/2019 - 06/2007
2	Autolysis 01/2017 - 10/2010
2	Bacterial Endocarditis 10/2006 - 09/2006
1	Foodborne Diseases 01/2018
1	Colonic Neoplasms (Colon Cancer) 07/2017
1	Neoplasms (Cancer) 07/2017
1	Intraabdominal Infections 01/2017
1	Hemorrhage 03/2016
1	Osteomyelitis 06/2012
1	Cross Infection (Nosocomial Infection) 10/2008
1	Fever (Fevers) 11/2003

Drug/Important Bio-Agent (IBA)

15	Vancomycin FDA LinkGeneric 01/2020 - 02/2003
11	Anti-Bacterial Agents (Antibiotics)IBA 10/2020 - 11/2003
11	CollagenIBA 11/2018 - 03/2002
10	Proteins (Proteins, Gene)FDA Link 11/2018 - 09/2003
9	Daptomycin FDA Link 01/2020 - 11/2007
8	Cefazolin (Ancef)FDA LinkGeneric 01/2021 - 11/2003
8	Methicillin (Metin)FDA Link 01/2021 - 11/2003
7	Virulence Factors (Pathogenicity Factors)IBA 01/2017 - 03/2003
5	Linezolid (Zyvox)FDA Link 01/2019 - 02/2007
4	Ampicillin (Omnipen)FDA LinkGeneric 01/2020 - 11/2007
4	Bile Acids and Salts (Bile Acids)IBA 01/2017 - 11/2005
3	Monoclonal AntibodiesIBA 11/2018 - 04/2014
3	Pharmaceutical PreparationsIBA 01/2017 - 10/2008
3	Fibronectins (Fibronectin)IBA 12/2015 - 01/2006
3	Fibrinogen (Factor I)FDA Link 05/2015 - 07/2011
3	AntibodiesIBA 04/2014 - 07/2004
3	AminoglycosidesIBA 05/2013 - 03/2009
3	Polysaccharides (Glycans)IBA 09/2009 - 04/2002
3	AntigensIBA 09/2009 - 03/2002
3	GelatinasesIBA 08/2005 - 05/2004
2	omadacyclineIBA 01/2021 - 01/2021
2	Gentamicins (Gentamicin)FDA LinkGeneric 01/2021 - 11/2007
2	Ertapenem (Invanz)FDA Link 12/2020 - 01/2018
2	tedizolidIBA 01/2020 - 01/2019
2	salicylhydroxamic acid (SHAM)IBA 11/2018 - 01/2010
2	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2018 - 01/2017
2	Ceftaroline FDA Link 01/2018 - 01/2017
2	Phosphotransferases (Kinase)IBA 01/2016 - 06/2013
2	Peptidoglycan (Murein)IBA 04/2014 - 10/2010
2	beta-Lactamases (beta-Lactamase)IBA 09/2013 - 11/2003
2	ceftobiprole medocarilIBA 06/2012 - 09/2007
2	Tigecycline (Tygacil)FDA Link 04/2012 - 02/2003
2	Extracellular Matrix ProteinsIBA 07/2011 - 12/2008
2	1- (5'- O- sulfamoyl- beta- ribofuranosyl)(1,2,4)triazole- 3- thiocarboxamideIBA 11/2007 - 10/2006
2	Collagen Type I (Type I Collagen)IBA 01/2006 - 03/2003
1	Tetracycline (Achromycin)FDA LinkGeneric 01/2021
1	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2021
1	S 10 (S-10)IBA 01/2019
1	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 11/2018
1	Ethanolamine (Colamine)IBA 01/2018
1	Adenosine Monophosphate (AMP)IBA 01/2018
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 07/2017
1	CateninsIBA 07/2017
1	N-Acetylmuramoyl-L-alanine Amidase (Autolysin)IBA 01/2017
1	Fimbriae Proteins (Pilin)IBA 01/2017
1	telavancin FDA Link 01/2017
1	Ribonucleases (Ribonuclease)IBA 01/2017
1	Indomethacin (Indometacin)FDA LinkGeneric 03/2016
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 03/2016
1	Hemoglobins (Hemoglobin)IBA 03/2016
1	CarbohydratesIBA 01/2016
1	Membrane Transport Proteins (Biological Pump)IBA 01/2016
1	Carrier Proteins (Binding Protein)IBA 12/2015
1	Lipoproteins (Lipoprotein)IBA 06/2015
1	bacitracin AIBA 06/2015
1	Initiator Codon (Start Codon)IBA 05/2015
1	Nafcillin FDA LinkGeneric 09/2013
1	23S Ribosomal RNAIBA 07/2013
1	Anti-Infective Agents (Microbicides)IBA 06/2013
1	ceftobiproleIBA 06/2012
1	oritavancinIBA 04/2012
1	quinupristin-dalfopristin (Synercid)FDA Link 04/2012
1	esp enterococcal surface proteinIBA 12/2011
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2010
1	Cephalosporins (Cephalosporin Antibiotics)IBA 08/2009
1	Immunoglobulins (Immunoglobulin)IBA 09/2006
1	protease SIBA 08/2005
1	Serine Proteases (Serine Protease)IBA 08/2005
1	Erythromycin (Erycette)FDA LinkGeneric 08/2003
1	cethromycinIBA 08/2003
1	CL 331002 (glycylcycline)IBA 02/2003
1	TetracyclinesIBA 02/2003
1	Laminin (Merosin)IBA 03/2002

Therapy/Procedure

10	Therapeutics 12/2020 - 11/2003
1	Salvage Therapy 12/2020
1	Liver Transplantation 01/2017
1	Indwelling Catheters (Indwelling Catheter) 01/2017
1	Aftercare (After-Treatment) 09/2011
1	Renal Dialysis (Hemodialysis) 08/2009
1	Drug Therapy (Chemotherapy) 06/2007
1	Immunotherapy 10/2006
1	Catheters 12/2005